 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Audit |
|
| Screening |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
Registered Charity 269736
|
|
|
Screening Audit
The annual ABS at BASO audit of screen detected breast cancers was undertaken to examine NHS Breast Screening Programme surgical activity and was designed to assess surgical performance by comparison of data with as many as possible of the surgical Quality Assurance standards recommended by the UK NHS Breast Screening Programme.
- The number and invasive status of screen detected breast cancers
- Non-operative diagnosis and use of diagnostic open biopsy
- Treatment and size of all cancers
- Lymph node status, invasive grade and NPI score
- Waiting times
- Surgical caseload
- Repeat therapeutic operations
- Adjuvant therapy
- Survival analysis
For more details of the audit and to download the latest publication, please go to WMCIU website
or NHS Cancer Screening website
Contact person:
ABS at BASO Breast Audit Steering Group
Dr Gill Lawrence
Director of Breast Screening Quality Assurance
West Midlands Cancer Intelligence Unit
Public Health Building
The University of Birmingham
Birmingham B15 2TT
E-mail: qarc@wmciu.nhs.uk
|
|
